Effects of Dynamine Ingestion on Various Indices of Sustained Energy

Completed · Not applicable · Has a placebo group

Conditions studied: Energy

In brief

This study is a randomized, placebo-controlled, double-blind, within-subject crossover trial of 25 men and women. The objective of this study is to assess the effects of Dynamine (methylliberine) supplementation on overall well-being including energy, sustained energy, mental stamina, focus, concentration, motivation to accomplish difficult tasks, drive, vigor, positive outlook, maintaining a healthy mood, feelings of well-being, and resilience to stress.

Key facts

Study ID

NCT06048640

Run by

The Center for Applied Health Sciences, LLC

People needed

25

Starts

2022-09-30

Expected to finish

2023-07-21

Last updated by the study team

2023-09-22

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• provide voluntary signed and dated informed consent
• in good health as determined by physical examination and medical history
• between the ages of 21 and 55 years
• body mass index (BMI) of 18.5-27 kg•m-2
• agrees to abstain from exercise and alcohol for 24 hours prior to each study visit
• agrees to abstain from coffee and caffeinated beverages for 12 hours prior to each study visit
• normotensive (seated, resting systolic blood pressure <140 mm Hg and diastolic blood pressure < 90 mm Hg
• normal seated, resting heart rate (<90 per minute)
• willing to duplicate their previous 24-hour and fast for 8 hours prior each study visit

You may not qualify if…

• a history of diabetes or pre-diabetes
• a history of malignancy in the previous 5 years except for non-melanoma skin cancer
• prior gastrointestinal bypass surgery
• known gastrointestinal or metabolic diseases that might impact nutrient absorption or metabolism
• any chronic inflammatory condition or disease
• a known allergy to any of the ingredients in the supplement or the placebo
• currently participating in another research study with an investigational product or have been in another research study in the previous 30 days
• a caffeine intake of three or more cups of coffee or equivalent (>400 mg) per day
• uses corticosteroids or testosterone replacement therapy (ingestion, injection, or transdermal)
• had any other diseases or conditions that, in the opinion of the medical staff, could confound the primary endpoints or place the participant at increased risk of harm if they were to participate

Where it is running

• The Center for Applied Health Sciences — Canfield, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.